What is Prinzmetal's angina?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 28, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Prinzmetal's Angina: Definition and Management

Prinzmetal's angina (variant angina) is a form of unstable angina characterized by transient coronary artery spasm causing temporary ST-segment elevation that resolves spontaneously or with nitroglycerin, typically occurring at rest without progression to myocardial infarction. 1

Clinical Characteristics

  • Timing and Presentation:

    • Occurs predominantly at rest, often in the early morning hours
    • Episodes frequently occur in clusters with asymptomatic periods lasting weeks to months
    • Chest pain is not typically precipitated by increased myocardial oxygen demand
    • May simulate unstable angina/NSTEMI secondary to coronary atherosclerosis 1
  • Triggers:

    • Emotional stress
    • Hyperventilation
    • Exercise (less commonly)
    • Exposure to cold 1
  • Patient Demographics:

    • Patients are typically younger than those with chronic stable angina
    • Often have fewer coronary risk factors except for smoking
    • More common in women 2
    • Associated with other vasospastic disorders like migraine headache and Raynaud's phenomenon 1, 2

Pathophysiology

The underlying mechanism involves:

  • Endothelial dysfunction exposing medial smooth muscle to vasoconstrictors:

    • Catecholamines
    • Thromboxane A2
    • Serotonin
    • Histamine
    • Endothelin 1
  • Imbalance between vasodilator factors (prostacyclin, nitric oxide) and vasoconstrictor factors (endothelin, angiotensin II) 1

  • Autonomic nervous system involvement with:

    • Reduced parasympathetic tone
    • Enhanced reactivity of alpha-adrenergic vascular receptors 1
  • Coronary anatomy:

    • Spasm is typically focal but can occur at multiple sites simultaneously
    • Can occur in angiographically normal or diseased vessels
    • Even "normal" coronary segments often have evidence of mural atherosclerosis on intravascular ultrasound 1, 2

Diagnosis

The key diagnostic finding is documentation of ST-segment elevation during transient chest discomfort that resolves when pain abates 1.

Diagnostic Approach:

  1. ECG monitoring during episodes of chest pain

    • Continuous 12-lead ECG monitoring improves diagnostic sensitivity
  2. Exercise testing

    • One-third show ST-segment elevation
    • One-third show ST-segment depression
    • One-third show no ST-segment changes
    • Results may not be reproducible and are more often positive in early morning 1
  3. Coronary angiography

    • Recommended in patients with episodic chest pain accompanied by transient ST-segment elevation (Class I recommendation) 1
    • Spasm may develop spontaneously during angiography, aiding diagnosis
    • Reveals that many patients have underlying coronary artery disease:
      • 39% have single-vessel disease
      • 19% have multi-vessel disease 1
  4. Provocative testing

    • May be considered in patients with no significant angiographic CAD and no documentation of transient ST-segment elevation (Class IIb recommendation)
    • Not recommended in patients with high-grade obstructive stenosis (Class III recommendation)
    • Tests include cold pressor test, hyperventilation, or pharmacological agents 1

Treatment

First-Line Therapy:

Treatment with nitrates and calcium channel blockers is recommended (Class I recommendation) 1.

  1. Nitrates:

    • Nitroglycerin is exquisitely effective in relieving acute spasm
    • Long-acting nitrates for prevention
  2. Calcium Channel Blockers:

    • First-line agents for long-term management
    • Verapamil dilates coronary arteries and is a potent inhibitor of coronary artery spasm 3
    • Typical dosing:
      • Verapamil: 240-480 mg per day
      • Diltiazem: 180-360 mg per day
      • Nifedipine: 60-120 mg per day 1
    • Combination of different classes may be needed for refractory cases
  3. Risk Factor Modification:

    • Smoking cessation is essential
    • Patients with atherosclerotic lesions are considered higher risk 1

Special Considerations:

  • Beta-blockers have theoretical adverse potential and are generally contraindicated in Prinzmetal's angina 2
  • Alpha-receptor blockers may benefit patients not responding to calcium channel blockers and nitrates 1
  • Percutaneous coronary intervention may be considered in patients with chest pain, transient ST-segment elevation, and significant coronary artery stenosis (Class IIb recommendation) 1

Prognosis and Complications

  • Prognosis is generally good when there is no significant coronary artery stenosis

  • When associated with coronary atherosclerosis, prognosis is determined by the severity of underlying disease 2

  • Potential complications:

    • Myocardial infarction
    • High-degree AV block
    • Life-threatening ventricular tachycardia
    • Sudden death 1

Prompt recognition and appropriate management with calcium channel blockers and nitrates are essential to prevent these potentially serious complications.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Prinzmetal's angina.

American journal of critical care : an official publication, American Association of Critical-Care Nurses, 2004

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.